IB Biology HL 1.2.18 Polypeptide modification Question Bank
Practise IB Biology HL 1.2.18 by applying polypeptide modification concepts to exam-style questions.
- Syllabus
- First assessment 2025
- Course
- Biology HL
- Level
- HL
Exam points
- identify the relevant biological structure, process or evidence
- apply the correct biological mechanism to the question
- evaluate the result using data, adaptation or ecological reasoning
D1.2.18 (HL)—Polypeptide modification question 1
Type I diabetes is a leading cause of death in advanced countries and is associated with various severe or fatal complications, including blindness, kidney failure, heart disease, stroke, neuropathy, and amputations. Embryonic stem cells are considered to be a powerful tool in the treatment of diabetes.
In a study, embryonic stem cells were grown in culture and tested for insulin mRNA. A drug was injected into two groups of healthy mice in order to simulate type I diabetes 15 days prior to the transplant of embryonic stem cells. The mice in the transplant group received embryonic stem cells that produce insulin mRNA. The control group did not receive the transplant. The graph shows the blood glucose concentration in both groups.
Insulin is produced by cutting C -peptide from the precursor molecule proinsulin. Suggest why group 1 has a greater level of C-peptide than group 2.
All question bank results loaded